Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 431

1.

Food Bioactive Compounds and Their Interference in Drug Pharmacokinetic/Pharmacodynamic Profiles.

Briguglio M, Hrelia S, Malaguti M, Serpe L, Canaparo R, Dell'Osso B, Galentino R, De Michele S, Dina CZ, Porta M, Banfi G.

Pharmaceutics. 2018 Dec 14;10(4). pii: E277. doi: 10.3390/pharmaceutics10040277. Review.

2.

Albumin uptake and distribution in the zebrafish liver as observed via correlative imaging.

Cheng D, Morsch M, Shami GJ, Chung RS, Braet F.

Exp Cell Res. 2019 Jan 1;374(1):162-171. doi: 10.1016/j.yexcr.2018.11.020. Epub 2018 Nov 26.

PMID:
30496757
3.

Quantitative PET of liver functions.

Keiding S, Sørensen M, Frisch K, Gormsen LC, Munk OL.

Am J Nucl Med Mol Imaging. 2018 Apr 25;8(2):73-85. eCollection 2018. Review.

4.

Organic solute carrier 22 (SLC22) family: Potential for interactions with food, herbal/dietary supplements, endogenous compounds, and drugs.

Lai RE, Jay CE, Sweet DH.

J Food Drug Anal. 2018 Apr;26(2S):S45-S60. doi: 10.1016/j.jfda.2018.03.002. Epub 2018 Mar 24. Review.

5.

Hepatic Transport of 25-Hydroxyvitamin D3 Conjugates: A Mechanism of 25-Hydroxyvitamin D3 Delivery to the Intestinal Tract.

Gao C, Liao MZ, Han LW, Thummel KE, Mao Q.

Drug Metab Dispos. 2018 May;46(5):581-591. doi: 10.1124/dmd.117.078881. Epub 2018 Feb 21.

PMID:
29467214
6.

Functional assessment of hepatobiliary secretion by 11C-cholylsarcosine positron emission tomography.

Ørntoft N, Frisch K, Ott P, Keiding S, Sørensen M.

Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1240-1244. doi: 10.1016/j.bbadis.2017.11.016. Epub 2017 Dec 2. Review.

PMID:
29197661
7.

Organic Anion-Transporting Polypeptide and Efflux Transporter-Mediated Hepatic Uptake and Biliary Excretion of Cilostazol and Its Metabolites in Rats and Humans.

Wang C, Huo X, Wang C, Meng Q, Liu Z, Sun P, Cang J, Sun H, Liu K.

J Pharm Sci. 2017 Sep;106(9):2515-2523. doi: 10.1016/j.xphs.2017.05.011. Epub 2017 May 20.

PMID:
28535976
8.

Evaluation of New Chemical Entities as Substrates of Liver Transporters in the Pharmaceutical Industry: Response to Regulatory Requirements and Future Steps.

Okudaira N.

J Pharm Sci. 2017 Sep;106(9):2251-2256. doi: 10.1016/j.xphs.2017.05.009. Epub 2017 May 19. Review.

PMID:
28533120
9.

Understanding the Potential Interethnic Difference in Rosuvastatin Pharmacokinetics.

Benet LZ, Wu HF.

J Pharm Sci. 2017 Sep;106(9):2231-2233. doi: 10.1016/j.xphs.2017.05.008. Epub 2017 May 11.

PMID:
28502797
10.

Possible Role of Organic Cation Transporters in the Distribution of [11C]Sulpiride, a Dopamine D2 Receptor Antagonist.

Takano H, Ito S, Zhang X, Ito H, Zhang MR, Suzuki H, Maeda K, Kusuhara H, Suhara T, Sugiyama Y.

J Pharm Sci. 2017 Sep;106(9):2558-2565. doi: 10.1016/j.xphs.2017.05.006. Epub 2017 May 10.

PMID:
28499878
12.

Involvement of Organic Cation Transporters in the Kinetics of Trimethylamine N-oxide.

Miyake T, Mizuno T, Mochizuki T, Kimura M, Matsuki S, Irie S, Ieiri I, Maeda K, Kusuhara H.

J Pharm Sci. 2017 Sep;106(9):2542-2550. doi: 10.1016/j.xphs.2017.04.067. Epub 2017 May 4.

PMID:
28479364
13.

Understanding the Interplay Between Uptake and Efflux Transporters Within In Vitro Systems in Defining Hepatocellular Drug Concentrations.

Cantrill C, Houston JB.

J Pharm Sci. 2017 Sep;106(9):2815-2825. doi: 10.1016/j.xphs.2017.04.056. Epub 2017 May 3.

PMID:
28478131
14.

Effect of Liver Disease on Hepatic Transporter Expression and Function.

Thakkar N, Slizgi JR, Brouwer KLR.

J Pharm Sci. 2017 Sep;106(9):2282-2294. doi: 10.1016/j.xphs.2017.04.053. Epub 2017 Apr 30. Review.

15.

Analysis of Nonlinear Pharmacokinetics of a Highly Albumin-Bound Compound: Contribution of Albumin-Mediated Hepatic Uptake Mechanism.

Fukuchi Y, Toshimoto K, Mori T, Kakimoto K, Tobe Y, Sawada T, Asaumi R, Iwata T, Hashimoto Y, Nunoya KI, Imawaka H, Miyauchi S, Sugiyam Y.

J Pharm Sci. 2017 Sep;106(9):2704-2714. doi: 10.1016/j.xphs.2017.04.052. Epub 2017 Apr 30.

PMID:
28465151
16.

Hepatobiliary Clearance Prediction: Species Scaling From Monkey, Dog, and Rat, and In Vitro-In Vivo Extrapolation of Sandwich-Cultured Human Hepatocytes Using 17 Drugs.

Kimoto E, Bi YA, Kosa RE, Tremaine LM, Varma MVS.

J Pharm Sci. 2017 Sep;106(9):2795-2804. doi: 10.1016/j.xphs.2017.04.043. Epub 2017 Apr 27.

PMID:
28456723
17.

Imaging Probes and Modalities for the Study of Solute Carrier O (SLCO)-Transport Function In Vivo.

Marie S, Cisternino S, Buvat I, Declèves X, Tournier N.

J Pharm Sci. 2017 Sep;106(9):2335-2344. doi: 10.1016/j.xphs.2017.04.031. Epub 2017 Apr 25. Review.

PMID:
28454744
18.

Using quantitative intravital multiphoton microscopy to dissect hepatic transport in rats.

Dunn KW, Ryan JC.

Methods. 2017 Sep 1;128:40-51. doi: 10.1016/j.ymeth.2017.04.015. Epub 2017 Apr 21.

19.

Rosuvastatin Pharmacokinetics in Asian and White Subjects Wild Type for Both OATP1B1 and BCRP Under Control and Inhibited Conditions.

Wu HF, Hristeva N, Chang J, Liang X, Li R, Frassetto L, Benet LZ.

J Pharm Sci. 2017 Sep;106(9):2751-2757. doi: 10.1016/j.xphs.2017.03.027. Epub 2017 Apr 3.

20.

Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease.

Stieger B, Mahdi ZM.

J Pharm Sci. 2017 Sep;106(9):2295-2301. doi: 10.1016/j.xphs.2017.03.023. Epub 2017 Apr 3. Review.

PMID:
28385542

Supplemental Content

Loading ...
Support Center